BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6710076)

  • 41. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.
    Dieterich W; Esslinger B; Trapp D; Hahn E; Huff T; Seilmeier W; Wieser H; Schuppan D
    Gut; 2006 Apr; 55(4):478-84. PubMed ID: 16188922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coeliac disease. The small intestine at autopsy.
    Thompson H
    Clin Gastroenterol; 1974 Jan; 3(1):171-81. PubMed ID: 4600389
    [No Abstract]   [Full Text] [Related]  

  • 44. [Degranulation of mast cells of the small intestine after a single gliadin loading in celiac disease].
    Horváth K; Simon K; Horn G; Rudas G; Bodánszky H
    Orv Hetil; 1986 Mar; 127(9):515-6, 519. PubMed ID: 3960532
    [No Abstract]   [Full Text] [Related]  

  • 45. Toxicity of gliadin in coeliac patients.
    Patey AL
    Lancet; 1980 Aug; 2(8191):427-8. PubMed ID: 6105547
    [No Abstract]   [Full Text] [Related]  

  • 46. Toxicity of wheat flour proteins and protein-derived peptides for in vitro developing intestine from rat fetus.
    De Ritis G; Occorsio P; Auricchio S; Gramenzi F; Morisi G; Silano V
    Pediatr Res; 1979 Nov; 13(11):1255-61. PubMed ID: 390482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulation of lymphocytes from patients with coeliac disease by subfraction of gluten.
    Lancet; 1976 Sep; 2(7986):629-30. PubMed ID: 61364
    [No Abstract]   [Full Text] [Related]  

  • 48. Morphological and morphometric assessment of human duodenal biopsies maintained in organ culture. In vitro influences of gluten in coeliac disease.
    Fluge G; Aksnes L
    Scand J Gastroenterol; 1981; 16(4):555-67. PubMed ID: 7323692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coeliac disease: the abolition of gliadin toxicity by enzymes from Aspergillus niger.
    Phelan JJ; Stevens FM; McNicholl B; Fottrell PF; McCarthy CF
    Clin Sci Mol Med; 1977 Jul; 53(1):35-43. PubMed ID: 872519
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraepithelial lymphocytes in jejunal mucosa: diagnostic significance of changes in their number during chronic intestinal disease, with particular reference to coeliac disease.
    Saputo V; Losi S; Mancosu M; Della Morte MA; Moschettini GF
    Schweiz Rundsch Med Prax; 1981 Jul; 70(30):1342-8. PubMed ID: 7267614
    [No Abstract]   [Full Text] [Related]  

  • 51. Isolation of coeliac active peptide fractions from gliadin.
    Wieser H; Belitz HD; Ashkenazi A; Idar D
    Z Lebensm Unters Forsch; 1983; 176(2):85-94. PubMed ID: 6405556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of gliadin-derived peptides from bread and durum wheats on in vitro cultures of human cell lines. Implications for coeliac disease pathogenesis.
    Rocca E; Paganuzzi Stammati A; Zampaglioni F; Zucco F
    Toxicol Lett; 1983 May; 16(3-4):331-8. PubMed ID: 6857727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A quantitative assessment of jejunal villous damage in coeliac disease, using the mucosal index.
    Challacombe DN; McDonald DT; Wheeler EE
    Hepatogastroenterology; 1983 Jun; 30(3):113-5. PubMed ID: 6884972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relation of antigenic structure of cereal proteins to their toxicity in coeliac patients.
    Ciclitira PJ; Ellis HJ; Evans DJ; Lennox ES
    Br J Nutr; 1985 Jan; 53(1):39-45. PubMed ID: 2415155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The clinical significance of anti-gliadin antibodies determination in blood of children with suspected celiac diseases].
    van der Meer BW; Mearin ML; Peña AS; van Tol MJ; Lamers CB; Dooren LJ
    Tijdschr Kindergeneeskd; 1993 Feb; 61(1):7-12. PubMed ID: 8493702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Changes in the rat intestinal mucosa after the in vivo administration of wheat germ agglutinin and gliadin].
    Saccia M; Rutigliano V; Rigillo N; Bosco L; Rizzo G; Fini M
    Boll Soc Ital Biol Sper; 1987 Mar; 63(3):209-16. PubMed ID: 3651242
    [No Abstract]   [Full Text] [Related]  

  • 57. Re-evaluation of the techique of organ culture for studying gluten toxicity in coeliac disease.
    Hauri HP; Kedinger M; Haffen K; Gaze H; Hadorn B; Hekkens W
    Gut; 1978 Dec; 19(12):1090-8. PubMed ID: 744495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gluten-sensitive enteropathy.
    Luchetti R; De Vincenzi M
    Ann Ist Super Sanita; 1995; 31(3):323-36. PubMed ID: 8712576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The toxicity of certain cereal proteins in coeliac disease.
    Cornell HJ; Townley RR
    Gut; 1974 Nov; 15(11):862-9. PubMed ID: 4455563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease.
    Matysiak-Budnik T; Candalh C; Cellier C; Dugave C; Namane A; Vidal-Martinez T; Cerf-Bensussan N; Heyman M
    Gastroenterology; 2005 Sep; 129(3):786-96. PubMed ID: 16143118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.